Novo Nordisk shares jump after US approves Wegovy pill
Novo Nordisk shares jumped 10% today after the US Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival Eli Lilly in the fast-evolving market for obesity drugs.
Business
• 23 Dec 25
